Results 261 to 270 of about 2,645,770 (342)

Characteristics of upper and lower respiratory tract microbiota after lung transplantation. [PDF]

open access: yesRespir Res
Cai Y   +9 more
europepmc   +1 more source

Unilateral lung transplantation for Eisenmenger's syndrome

open access: bronze, 1992
Bernard Kreitmann, D Métras, M Badier
openalex   +1 more source

Diosgenin ameliorates silica‐induced tuberculosis in rats

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Silicosis increases susceptibility to tuberculosis due to impaired macrophage function and oxidative stress. This study demonstrates that diosgenin, a steroidal saponin, significantly inhibits Mycobacterium smegmatis (IC₅₀ = 0.006 μg/mL), reduces lung fibrosis, and restores antioxidant enzyme levels (↑SOD, ↑CAT, ↓MDA) in silica‐exposed rats ...
Williams Asamoah Adu   +5 more
wiley   +1 more source

Poor risk-benefit ratio of gastrointestinal endoscopy for screening prior to heart or lung transplantation. [PDF]

open access: yesSurg Endosc
Ehlken H   +6 more
europepmc   +1 more source

In-storage Hypothermic Perfusion for Heart and Lung Transplantation

open access: bronze, 1992
Masaya Kitamura   +9 more
openalex   +1 more source

Development of an efficient mice model of cancer‐associated cardiac cachexia

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This work establishes a preclinical framework for targeting ubiquitin pathways to mitigate the morbidity of cancer‐related cardiopathy. Our integrated approach delineates a hierarchical progression from subcellular dysfunction to macroscopic cardiac deterioration. These findings mechanistically link tumor‐induced cachexia to cardiac dysfunction through
Shijie Xiong   +9 more
wiley   +1 more source

COVID-19's impact on heart and lung transplantation: Citation-based analysis of research output. [PDF]

open access: yesWorld J Transplant
Yaghmour N   +7 more
europepmc   +1 more source

Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension

open access: bronze, 1994
Ko Bando   +10 more
openalex   +1 more source

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond

open access: yesAnnals of Neurology, EarlyView.
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr.   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy